One-stop source for cardiology news and links

Home
About

Editor: “Close to 10% of the papers we receive show some sign of academic misconduct”

September 19, 2013 by Larry Husten Leave a Comment

Filed Under: Uncategorized

Speak Your Mind Cancel reply

Name *

Email *

Website

Δ

Recent Comments

Dr Waykup on What Can We Learn From The Apple Heart Study?
Y K Lau on Pioneering Cardiologist George Diamond Dead At 74
Ellie Kesselman on Right Wing Minority Rule
Jack frost on Conflicts of Interest in Cardiovascular Guidelines
Thomas Via on Amgen Requires Patients in Repatha Copay Program To Surrender Their Privacy

Archives

Archives

Note to Readers: A Time For Change

Click here to read about important new changes to CardioBrief.

Follow Cardiobrief on Twitter

Developed By: SKSDEV

CardioBrief Classics

Coca-Cola, The Olympic Torch, And The American College Of Cardiology

Stem Cell Therapy Company Hypes Preliminary Results

Good Science/Bad Science: Contrasting Papers On Dietary Compositon In JAMA And BMJ

Subway Meals Get American Heart Association Endorsement

This Week In Medicine: Stop Exercising and Eat Chocolate!

You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook

Politics and Transcatheter Aortic Valve Replacement

Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes

New Perspective on the Dutch Cardiovascular Research Scandal

Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart

And the 2012 Award For the Most Dumbass Drug Promotion Goes To…

You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook

Politics and Transcatheter Aortic Valve Replacement

Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes

Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart

Guest Post: More Lessons From the Riata ICD Lead Recall

Japanese Researcher With Harvard Connections Retracts 3 Articles in AHA Journals

Lancet Editor Richard Horton Tweets Dark View of Contemporary Medicine

Resveratrol and Fraud

Director of UConn CV Research Center Accused of Scientific Misconduct

2011 in Review: Rivaroxaban, Sapien, Mark Midei, Conflicts of Interest, and Much More

Nissen and Topol Clash Over Genetics and Personalized Medicine

Ray of Light for the Physician Payment Sunshine Act

Letter From Jail: A Cautionary Tale

One More Thought About Lipitor

Experts Clash Over Interpretation and Value of AIM-HIGH

Controversy Over Cholesterol Testing for Children

CardioBrief Poll: Should the ACC Train Industry Reps?

Daily Show Asks Why the AHA Killed a Bill Encouraging Healthy Behavior

National Lipid Association Expert Panel Has Many Deep Ties To Industry

Industry & Medicine: It’s Complicated

Easy Come, Easy Go? ESC To Review Dronedarone’s Role in AF Guidelines

The Pen Is Mightier Than the Scold

CNN Documentary Promises Screening and Vegan Diet Can Eliminate Heart Attacks

CNN, ABC, and NBC Dumb Down the News About CV Screening

US Senate Unanimously Endorses Campaign Against Atrial Fibrillation

Less May Be More, But Stents Are Neither Good Nor Bad

The Voice of the Patient: Time To Bring Out the Muzzle?

New Concerns Raised About Withdrawn Archives Meditation Paper

Archives Decides At Last Minute Not to Publish a Scheduled Paper

Part 2: The National Lipid Association And Industry

Part 1: The National Lipid Association and the FH Guidelines

Understanding Risk: Tricky Business

ACC CEO Jack Lewin Provides The Argument Against Industry Money

The ACC Counts Down To Launch Of New Satellites

Scientific Fraud Found In Wayne Alexander’s Research Group At Emory

$50K: The Price For A VIP Dinner For 2 With The Cleveland Clinic CEO

Evidence: The Weak Link Of Evidence-Based Medicine

Taking Medical Advice From Peggy Fleming?

The ACC Wants You To Know That Nothing Is Rotten In The State Of Maryland

An Embargo Becomes A Public Relations Tool

PROTECT II: Who Will Protect Us From The Protectors?

GRAVITAS Published: Who Gets To Weigh In On the Results?

WebMD: the 800 Pound Gorilla in the Room

Some Things Don’t Go Better With Coke

ACC and HRS Downplay Data From Their Own Registry

Dangling Doctors In Front of Journalists

Spinning Out of Control: Another Look at the PROTECT II Press Release

Questions Raised About Compensation and Conflicts at Duke

SHARP: A Tale of Two Press Releases

Will This Be the HDL Decade? REVEAL Revealed, Mixed Results for Apo-A1

CardioExchange at the AHA: A New Voice Emerges

Top New York City Interventional Cardiologists Now Making $3 Million a Year

The Plot Thickens in the Case of the Exploding ICD

Red light or green light for AAA screening?

Blue light special: AAA screening at Kmart in the disease-mongering aisle

The rise of the ESC: is the ESC anti-American or pro-industry?

Dronedarone and ticagrelor speed into ESC guidelines

The debate over CME and industry influence continues

Avandia aftermath: who are the winners and losers?

Debating medical promotion and education

Why is there a red dress on diet Coke cans?

SHAPE shifting: transforming guidelines into a business venture

Why was an Abbott marketing study published in the American Journal of Cardiology?

At the Dallas valve meeting even the faculty is for sale

A missing piece of the Multaq puzzle finally appears: DIONYSOS published to little fanfare

EHJ editors rebuffed GSK efforts to suppress Nissen editorial on rosiglitazone

“Is it safe?”

Why we shouldn’t kill all the lawyers just yet

Why is there a red dress on diet Coke cans?

Sunday at the AHA: ARBITER’s wild roller coaster ride in Orlando

Cardiology $$$: Mt Sinai’s Samin Sharma tops Columbia’s Moses

Residual Risk Reduction Initiative: promotion or education?

Editorial: the incompetence of the FDA

Editorial: SHAPE is skating on thin ice

Extreme cardiology culture: Califf, Harrington, Topol & Teirstein

October thought experiment: suppose the World Series were covered like the Nobel Prize

Live AF ablation broadcast on Today Show: what’s wrong with this picture?

More Multaq: Prystowsky whack-a-mole, ACC responds, Sanofi overtures to EPs

Pieces of a puzzle: Multaq, Sanofi, ACC, HRS, Prystowsky, AF Guidelines

My Google Plus Profile

Archives

Archives

"I’d rather read Larry Husten on clinical trials than the constipated editorials in peer review journals." --Saurabh Jha (The Health Care Blog)

Meta

Log in
Entries feed
Comments feed
WordPress.org

Return to top of page

Copyright © 2023 · Prose on Genesis Framework · WordPress · Log in